Welcome to: Rimonabant Information Source (rimonabant sanofi)

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 |
Effective weight loss with Rimonabant
- buy rimonabant buy acomplia
- rimonabant tablets
- rimonabant short term
- loose weight, rimonabant
- rimonabant fda approved
- rimonabant generic manufacturer
- rimonabant sanofi
Rimonabant Pricelist
Please wait while we load the price list
Sanofi-Aventis' Acomplia® tipped to be first Cannabinoid blockbuster.(PRWEB) August 12, 2007 -- Piribo, the online destination for business intelligence for the biotech and pharmaceutical industry, has now added a new report on the latest developments in the commercially marketed cannabinoids, in particular, Acomplia® (Rimonabant)."Rimonabant: The first of the Cannabinoid blockbusters" forecasts that in 2007, the cannabinoid market will generate $709 million revenue in sales. This represents a 45% growth from 2006, when this class of drugs brought in $386 million. Authors of the report say that cannabinoids like Acomplia®, Marinol®, Cesamet®, and Sativex® treat a variety of medical conditions ranging from weight-loss to pain relief.
Rimonabant Acomplia works by selectively targeting and blocking the CB1 receptors, helping normalize the over-activation of the EC system and making hunger or cigarette pangs more manageable. Rimonabant is a new anti-obesity drug, developed by Sanofi-Aventis, a french pharmaceutical company. If you are overweight rimonabant weight loss drug may help you shed pounds. As per recent marketing survey, it shows Approximately 300,000 adult deaths in the United States each year are attributable to unhealthy dietary habits and physical inactivity or sedentary behavior · Nearly two-thirds of U. S.adults are overweight (BMI > 25, which includes those who are obese).· Nearly one-third of U.
